capital markets

ECI, DiamondLake, and SteelWave merge to create integrated real asset platform targeting $5B portfolio in 36 months.

Telix Pharmaceuticals appoints experienced life sciences executive David Gill as Non-Executive Director, with planned succession to Chair role, bringing 35+ years of CFO and commercial expertise.

Ramaco Resources restructures into four independent divisions spanning metallurgical coal, critical minerals development, royalties, and processing to unlock shareholder value and enable future capital market access.

Kuntarahoitus Oyj issues €15 million bond maturing 2036 at 3.765% yield as part of its €50 billion MTN programme, listing on Nasdaq Helsinki in April 2026.

BluEnergies launches dual-listing on OTCQX ($BLUGF) and TSX Venture ($BLU), enhancing U.S. capital access for West Africa and Gulf of America oil and gas exploration.

Rogers Communications prices $2.5B dual-currency subordinated notes offering, with proceeds directed toward debt refinancing through 2056 maturity.

$AMFN appoints 30-year finance veteran Michael Carlson as CFO, completes independent audits, and files Form 10 with SEC.

Investec becomes first institutional member of FCA-authorised BPX digital securities marketplace, integrating via ZebrA-X platform. Partnership signals institutional adoption of tokenised asset infrastructure.

Kevin K. Albert, 40-year Wall Street veteran, joins Vintage Stone Capital as Senior Partner to scale industrial acquisition strategy in lower middle-market segment.

Crédit Agricole issues €228.5M senior bonds at 3.40% maturing 2036 while its Ukraine subsidiary acquires Bank Lviv, strengthening regional presence and capital position.

$RNWF completes PCAOB audit, files Form 10 with SEC. Pursuing OTCQB qualification and exploring national exchange listing with investment banking discussions ongoing.

Stifel hires veteran bankers Pathak and Reisner as Managing Directors to lead new healthcare banking practice, targeting hospitals and health systems.

Galaxy Corporation hosts Nasdaq VP in Seoul, reports H1 2025 revenue of KRW 126 billion with 200%+ YoY growth and returned profitability amid U.S. listing plans.

Cohen & Company reports explosive 246% revenue growth to $275.6M in 2025, with investment banking division closing $43B in transactions and commanding SPAC IPO market leadership.

CDT Equity acquires 20% stake in Sarborg AI for $115M while advancing AstraZeneca-licensed pharmaceuticals and exploring capital markets options.

Prediction market platform Polymarket could IPO in 2026 amid sector enthusiasm, but historical precedent suggests peak-hype IPOs significantly underperform.

BrightSpring announces $823M secondary stock offering at $41.15/share with concurrent $60M repurchase, closing March 4.

SEDA Experts LLC hires John Hardt as Managing Director, leveraging his 40+ years at Goldman Sachs, UBS, Citigroup, and other major banks.

GLPI priced $800M senior notes at 5.625% coupon to refinance debt and fund strategic initiatives, settling March 2026.

Kyverna appoints two biotech executives to its board ahead of cell therapy commercialization. New directors bring expertise from Beam Therapeutics and Karuna Therapeutics.